Purity, potency, and safety – affordably – in stem cell therapy

from pharmaphorum Podcast · host pharmaphorum

In a new episode of the pharmaphorum podcast, web editor Nicole Raleigh discusses stem cell therapy, and accessibility to and affordability of such treatment, with Rafael R Carazo Salas, founder and CEO of CellVoyant, an AI-first biotechnology company spun out from the University of Bristol.

Episode metadata supplied by the publisher feed · Published Jun 11, 2024

Embed this episode

Attribution link and audio player

NOW PLAYING

Purity, potency, and safety – affordably – in stem cell therapy

0:00 28:25

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of pharmaphorum Podcast?

This episode is 28 minutes long.

When was this pharmaphorum Podcast episode published?

This episode was published on June 11, 2024.

Can I download this pharmaphorum Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!